AbbVie Inc (BSP:ABBV34)
R$ 55.4 0.76 (1.39%) Market Cap: 1.57 Til Enterprise Value: 1.86 Til PE Ratio: 50.02 PB Ratio: 37.17 GF Score: 82/100

Q3 2020 Abbvie Inc Earnings Call Transcript

Oct 30, 2020 / 01:00PM GMT
Release Date Price: R$30.72 (+6.09%)
Operator

Good morning and thank you for standing by. Welcome to the AbbVie Third Quarter 2020 Earnings Conference Call. (Operator Instructions)

And I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.

Elizabeth Shea
AbbVie Inc. - VP of IR

Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; Rob Michael, Executive Vice President and Chief Financial Officer. And joining us for the Q&A portion of the call is Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer and Corporate Secretary.

Before we get started, I remind you that some statements we make today may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties, including the impact of the COVID-19 pandemic on AbbVie's operations, results and financial results that may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot